First-of-its kind hormone replacement therapy improves symptoms in patients with adrenal conditions

A first-of-its kind hormone replacement therapy that more closely replicates the natural circadian and ultradian rhythms of our hormones has shown to improve symptoms in patients with adrenal conditions.

Brain Aging Biomarkers; Midlife Anxiety and Dementia Risk; Who Chose Assisted Dying?

Researchers identified 13 proteins that predicted how quickly or slowly a person’s brain aged. (Nature Aging) Midlife anxiety was common decades before people developed dementia,

December 11, 2024

Two distinct types of fatty liver disease identified

Researchers at Karolinska Institutet and the University of Gothenburg have identified two types of metabolic-associated fatty liver disease – a liver-specific type and a systemic

December 10, 2024

LOXO-435 by Loxo Oncology for Solid Tumor: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.